National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 2967 [2024-00773]
Download as PDF
<![CDATA[
2967
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices
collection, the National Institute of
Health is collecting audience feedback
on a selection of survey questions and
research protocols. Parents/caregivers
and teens who are the same age as the
study cohort members but who are not
Study participants will review proposed
questions and give feedback on
questions’ clarity and acceptability.
Recommendations from these findings
help the ABCD Study team improve
their protocol for a more-successful data
collection.
Audience feedback activities will
include a mix of asynchronous and
scheduled, live data collection: webbased survey activities, virtual
discussion boards, individual
interviews, and discussions groups.
Assembling a cohort of audience
feedback participants who are familiar
with the ABCD Study and participate in
multiple data collection activities
minimizes the burden required to
familiarize new participants with the
purpose of the Study and the
expectations for audience feedback.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
172.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Average time
per response
(in hours)
Total annual
burden hour
(Parent/Caregiver Phone Screener) ..........................................
(Parent/Caregiver Consent) .......................................................
(Parent/Caregiver Permission for Teen Participation) ...............
(Teen Phone Screener) .............................................................
(Teen Assent or Consent) .........................................................
(Teen Web Survey) ...................................................................
(Parent/Caregiver Web Survey) ................................................
(Teen Virtual Group Discussion or Online Bulletin Board) .......
(Parent/Caregiver Virtual Interview) ..........................................
(Parent/Caregiver Online Bulletin Board) ..................................
(Parent/Caregiver ‘‘At-Home’’ Materials Review) ......................
72
15
36
72
36
36
15
36
15
15
15
1
1
1
1
1
2
2
2
1
1
1
5/60
5/60
5/60
5/60
10/60
30/60
30/60
1
30/60
1
15/60
6
1
3
6
6
36
15
72
8
15
4
Total ......................................................................................................
........................
450
..........................
172
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2024–00760 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2024–1 Phase I: Novel Diagnostic Biomarker
Discovery and Validation for Malaria and
VerDate Sep<11>2014
18:14 Jan 16, 2024
Jkt 262001
Select Neglected Tropical Diseases (NTDs)
(Topic 132).
Date: February 15, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747–7530, mairi.noverr@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Small Business Innovation
Research (SBIR) Phase II Program Contract
Solicitation (PHS 2022–1) Topic 108—
Development of Rapid POC Diagnostics for
Treponema pallidum (N01).
Date: February 16, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747–7530, mairi.noverr@
nih.gov.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00773 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Page 2967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00773]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2024-1 Phase
I: Novel Diagnostic Biomarker Discovery and Validation for Malaria
and Select Neglected Tropical Diseases (NTDs) (Topic 132).
Date: February 15, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747-7530, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Small Business Innovation Research
(SBIR) Phase II Program Contract Solicitation (PHS 2022-1) Topic
108--Development of Rapid POC Diagnostics for Treponema pallidum
(N01).
Date: February 16, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747-7530, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00773 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P
